Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
15 02 2022
Historique:
received: 27 07 2021
revised: 26 11 2021
accepted: 19 01 2022
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 12 3 2022
Statut: epublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused an ongoing global health crisis. Here, we present as a vaccine candidate synthetic SARS-CoV-2 spike (S) glycoprotein-coated lipid vesicles that resemble virus-like particles. Soluble S glycoprotein trimer stabilization by formaldehyde cross-linking introduces two major inter-protomer cross-links that keep all receptor-binding domains in the "down" conformation. Immunization of cynomolgus macaques with S coated onto lipid vesicles (S-LVs) induces high antibody titers with potent neutralizing activity against the vaccine strain, Alpha, Beta, and Gamma variants as well as T helper (Th)1 CD4

Identifiants

pubmed: 35233549
doi: 10.1016/j.xcrm.2022.100528
pii: S2666-3791(22)00028-3
pmc: PMC8784613
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
COVID-19 Vaccines 0
Immunoglobulin A 0
Immunoglobulin G 0
Liposomes 0
Spike Glycoprotein, Coronavirus 0
Vaccines, Virus-Like Particle 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100528

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Immunity. 2019 Nov 19;51(5):915-929.e7
pubmed: 31732167
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
PLoS Pathog. 2021 May 20;17(5):e1009576
pubmed: 34015061
Cell. 2020 Sep 17;182(6):1663-1673
pubmed: 32946786
Cell. 2021 May 27;184(11):2939-2954.e9
pubmed: 33852911
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2020 Dec;588(7838):498-502
pubmed: 32805734
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2021 Dec 03;374(6572):abm0829
pubmed: 34648302
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Immunol. 2020 Aug 15;205(4):915-922
pubmed: 32591393
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Nat Struct Mol Biol. 2021 Feb;28(2):128-131
pubmed: 33402708
Cell Rep Med. 2020 Jun 23;1(3):100040
pubmed: 32835303
Nat Med. 2021 Feb;27(2):270-278
pubmed: 33335323
Science. 2021 Aug 13;373(6556):818-823
pubmed: 34016740
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
J Biol Chem. 2014 Oct 24;289(43):29912-26
pubmed: 25160627
Science. 2020 Aug 14;369(6505):818-823
pubmed: 32616673
Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
Cell. 2020 Dec 10;183(6):1496-1507.e16
pubmed: 33171099
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Nat Commun. 2021 Mar 3;12(1):1403
pubmed: 33658497
Sci Rep. 2020 Oct 23;10(1):18149
pubmed: 33097791
Vaccine. 2020 Feb 24;38(9):2250-2257
pubmed: 31767462
Science. 2021 Aug 6;373(6555):642-648
pubmed: 34168070
Nat Commun. 2021 Sep 1;12(1):5215
pubmed: 34471122
Cell Host Microbe. 2021 Apr 14;29(4):522-528.e2
pubmed: 33789085
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33608249
Vaccine. 2020 Nov 25;38(50):7892-7896
pubmed: 33139139
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Cell. 2021 Mar 4;184(5):1188-1200.e19
pubmed: 33577765
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Nat Commun. 2020 May 4;11(1):2251
pubmed: 32366817
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
Cell. 2021 Apr 29;184(9):2384-2393.e12
pubmed: 33794143
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Science. 2021 Aug 6;373(6555):
pubmed: 34168071
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Science. 2021 Feb 12;371(6530):735-741
pubmed: 33436524
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nat Struct Mol Biol. 2020 Oct;27(10):934-941
pubmed: 32737467
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
Expert Opin Drug Deliv. 2016 Jun;13(6):807-16
pubmed: 26866300
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Nature. 2021 Jun;594(7862):253-258
pubmed: 33873199
Sci Adv. 2021 Sep 03;7(36):eabj5365
pubmed: 34516917
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6
pubmed: 33592168
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
Cell. 2020 Nov 12;183(4):1058-1069.e19
pubmed: 33058755
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
Science. 2020 Oct 9;370(6513):203-208
pubmed: 32817270
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Cell Host Microbe. 2021 Apr 14;29(4):516-521.e3
pubmed: 33798491
Nat Commun. 2021 Mar 1;12(1):1346
pubmed: 33649323
Science. 2020 Nov 6;370(6517):725-730
pubmed: 32958580
Immunity. 2017 May 16;46(5):804-817.e7
pubmed: 28514687
Vaccine. 2020 Oct 27;38(46):7205-7212
pubmed: 33010978
Cell Discov. 2020 Sep 3;6:61
pubmed: 32901211
J Virol. 2017 Jul 27;91(16):
pubmed: 28592540
Commun Biol. 2021 Jul 15;4(1):874
pubmed: 34267316
Nature. 2021 Feb;590(7847):630-634
pubmed: 33276369
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
Science. 2021 Apr 30;372(6541):525-530
pubmed: 33727252
iScience. 2021 Apr 23;24(4):102298
pubmed: 33723528
Science. 2020 Jun 12;368(6496):1274-1278
pubmed: 32404477
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Med J Aust. 2006 Feb 20;184(4):170-5
pubmed: 16489901
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Adv Virus Res. 2019;105:93-116
pubmed: 31522710
Science. 2020 Nov 20;370(6519):950-957
pubmed: 32972994
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
Sci Immunol. 2021 May 25;6(59):
pubmed: 34035118
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Nature. 2020 Aug;584(7821):443-449
pubmed: 32668443
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Elife. 2018 Nov 09;7:
pubmed: 30412051
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33067270
Cell. 2021 Mar 4;184(5):1201-1213.e14
pubmed: 33571429
Nat Commun. 2021 Jan 22;12(1):542
pubmed: 33483491
Cell Host Microbe. 2021 Jan 13;29(1):23-31.e4
pubmed: 33306985
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell Host Microbe. 2020 Sep 9;28(3):364-370
pubmed: 32798444
Front Immunol. 2018 Feb 05;9:155
pubmed: 29459867
Nature. 2020 Sep;585(7826):584-587
pubmed: 32698191
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033173
Cell Rep. 2021 Mar 23;34(12):108890
pubmed: 33713594
Sci Adv. 2021 May 28;7(22):
pubmed: 33888467
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Immunity. 2020 Jul 14;53(1):98-105.e5
pubmed: 32561270
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033172
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Cell Rep. 2016 May 31;15(9):1986-99
pubmed: 27210756
Nature. 2020 Sep;585(7824):268-272
pubmed: 32396922
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
J Struct Biol. 2013 Nov;184(2):226-36
pubmed: 23954653
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Vaccine. 2021 Jul 22;39(32):4423-4428
pubmed: 34210573
Science. 2021 Mar 25;:
pubmed: 33766944
Cell Rep Med. 2021 Apr 20;2(4):100252
pubmed: 33842900
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Nat Commun. 2021 Feb 8;12(1):848
pubmed: 33558493
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Guidenn Sulbaran (G)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Pauline Maisonnasse (P)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Axelle Amen (A)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Gregory Effantin (G)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Delphine Guilligay (D)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Nathalie Dereuddre-Bosquet (N)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Judith A Burger (JA)

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Location AMC, Amsterdam, the Netherlands.

Meliawati Poniman (M)

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Location AMC, Amsterdam, the Netherlands.

Marloes Grobben (M)

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Location AMC, Amsterdam, the Netherlands.

Marlyse Buisson (M)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Sebastian Dergan Dylon (S)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Thibaut Naninck (T)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Julien Lemaître (J)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Wesley Gros (W)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Anne-Sophie Gallouët (AS)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Romain Marlin (R)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Camille Bouillier (C)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Vanessa Contreras (V)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Francis Relouzat (F)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Daphna Fenel (D)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Michel Thepaut (M)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Isabelle Bally (I)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Nicole Thielens (N)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Franck Fieschi (F)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Guy Schoehn (G)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Sylvie van der Werf (S)

Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Université de Paris, Paris, France.
National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.

Marit J van Gils (MJ)

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Location AMC, Amsterdam, the Netherlands.

Rogier W Sanders (RW)

Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Location AMC, Amsterdam, the Netherlands.
Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.

Pascal Poignard (P)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Roger Le Grand (R)

Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.

Winfried Weissenhorn (W)

Univ. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale (IBS), Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH